DECOMPRESSIVE HEMICRANIECTOMY AFTER UNSUCCESSFUL INTRAVENOUS THROMBOLYSIS OF MALIGNANT MIDDLE CEREBRAL ARTERY INFARCTION: A CASE REPORT-Reference-Cited by-同舟云学术

DECOMPRESSIVE HEMICRANIECTOMY AFTER UNSUCCESSFUL INTRAVENOUS THROMBOLYSIS OF MALIGNANT MIDDLE CEREBRAL ARTERY INFARCTION: A CASE REPORT

Published:2023 Issue:3 Volume:25 Page:431-440
ISSN:2074-0581
Container-title:AVICENNA BULLETIN
language:
Short-container-title:AB

Author:

SEHWEIL S.M.,

Abstract

Methods: The gold standard treatment for patients with cerebral infarction (CI) is intravenous thrombolysis, and it is superior to standard therapy in improving functional status. Malignant middle cerebral artery infarction (MMCAI) is characterized by ischemic injury of 50% or more of the territory supplied by MCA, which, in turn, is a contraindication to thrombolytic therapy. When patients are admitted to the hospital within the therapeutic window before identification of a hypodense lesion by computed tomography, detecting the MMCAI promptly is challenging. Consequently, these patients receive intravenous thrombolysis. The article describes a successful decompressive hemicraniectomy (DHC) in a patient with MMCAI following ineffective, uncomplicated intravenous thrombolysis. Keywords: Malignant ischemic stroke, middle cerebral arter, decompressive hemicraniectomy, thrombolysis.

Publisher

Avicenna Tajik State Medical University

Subject

Psychiatry and Mental health

Reference31 articles.

1. 1. Gusev EI, Gekht AB. Klinicheskie rekomendatsii po provedeniyu tromboliticheskoy terapii pri ishemicheskom insul'te [Clinical guidelines for thrombolytic therapy in ischemic stroke] [Elektronnyy resurs]. 2015 [data dostupa: 2023 may 24]. Rezhim dostupa: http://minzdrav.saratov.gov.ru/1/Rekomendacii_TLT.pdf

2. 2. Kulesh AA, Dyomin DA. Vnutrivennyy trombolizis pri ishemicheskom insul'te: 10 pravil dlya prakticheskogo nevrologa [Intravenous thrombolysis in ischemic stroke: 10 rules for a practical neurologist]. Meditsinskiy sovet. 2022;16(21):175- 83. https://doi.org/10.21518/2079-701X-2022-16-21-175-183

3. 3. Dyomin TV, Musin ShG, Saykhunov MV, Kamalov IR, Khasanova DR. Opyt vnutrivennoy tromboliticheskoy terapii ishemicheskogo insul'ta v Respublike Tatarstan [Experience of intravenous thrombolytic therapy of ischemic stroke in the Republic of Tatarstan]. Effektivnaya farmakoterapiya. 2013;45:14-20.

4. 4. Domashenko MA, Maksimova MYu, Loskutnikov MA, Kistenev BA, Konovalov RN, Bryukhov VV, i dr. Sistemnyy medikomentoznyy trombolizis v ostreyshem periode ishemicheskogo insul'ta [Systemic drug thrombolysis in the acute period of ischemic stroke]. Annaly klinicheskoy i eksperimental'noy nevrologii. 2008;2(2):5-12.

5. 5. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. "Malignant" middle cerebral artery territory infarction: Clinical course and prognostic signs. Arch Neurol. 1996;53(4):309-315. https://doi.org/10.1001/archneur.1996.00550040037012